My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June 2016
EDUCATION AND RESOURCES
HIVMA Medical Student Program Aims to Inspire Careers in HIV
Sixteen medical students have been selected from across the US and Canada to receive funding for clinical learning and research projects through the HIVMA Medical Student Program. Housed within the IDSA Education and Research Foundation, the program is one of many initiatives that support IDSA’s strategic priority of attracting the best and brightest students to careers in ID and HIV.
 
The program supports work in local and overseas settings and includes projects as diverse as an evaluation of risk factors for tuberculosis among HIV patients, an analysis of microeconomic benefits of treating HIV, and the development of a decision-making tool to guide clinicians through treatment choices in patients with HIV drug-resistance. The awardees receive mentorship from HIVMA members at their institutions, free membership to HIVMA and IDSA, and a stipend of $3,500 per year for up to three years. 
 
The HIVMA Medical Student Program is supported by independent grants from ViiV Healthcare and the Gilead Foundation. More information on the program is available online
 
2016 HIVMA Medical Student Program Awardees: 
 
Colleen Walsh Lang, Washington University in St. Louis School of Medicine. "Children Living with HIV/AIDS in Uganda: Managing Biomedical and Social Consequences." MENTOR: Bradley Stoner, MD, PhD, FIDSA 
 
Jesús Luévano, Harvard Medical School. "Impact of HIV-Associated Changes in the Gut Microbiome on Disease Progression." MENTOR: Douglas S. Kwon, MD, PhD 
 
Sarah Rutstein, University of North Carolina at Chapel Hill. "Cost-effectiveness of Treating Depression to Improve HIV Care Outcomes in Malawi." MENTOR: Mina C. Hosseinipour, MD, MPH 
 
Sunaina Kapoor, Johns Hopkins University School of Medicine. "Development and Implementation of an Interactive Decision Support Tool for Anti-retroviral Therapy Selection (ART) in HIV Patients." MENTOR: Maunank Shah, MD, PhD 
 
Andrew Flynn, University of Minnesota. "Determinants of HIV Prevalence Changes in Uganda 2004-2011." MENTOR: David Boulware, MD, MPH, CTropMed 
 
Carlos Rodriguez-Russo, Warren Alpert Medical School of Brown University. "The Impact of Enrollment in Targeted Medicaid Home and Community-Based Services on Hospitalization and Institutional Care Use Among Aging HIV+ Patients." MENTOR: Ira Wilson, MD, MSc 
 
Clara Van Ommen, University of British Columbia. "Exploring the Triad of Telomeres, HIV and Ovarian Aging." MENTOR: Melanie Murray, MD, PhDNishant Munugala, University of Miami Miller School of Medicine. “The Impact of Health Numeracy on Attitudes Toward PrEP for HIV Prevention." MENTOR: Susanne Doblecki-Lewis, MD 
 
Rustin Zomorodi, Case Western Reserve University School of Medicine. "Increasing PrEP Uptake in High-Risk MSM Through Community- and Provider-Focused Interventions." MENTOR: Ann Avery, MD 
 
Vanessa Kung, University of Wisconsin-Madison. "Leveraging HIV Surveillance Data to Inform PrEP Implementation Among Young, Black Men Who Have Sex with Men." MENTOR: Ryan Westergaard, MD, PhD, MPH 
 
Bryna Harrington, University of North Carolina at Chapel Hill. "Perinatal Depression, Retention in HIV Care, and Viral Load Suppression Among Malawian Women Enrolled in Option B+." MENTOR: Mina C. Hosseinipour, MD, MPH 
 
Gregory Damhorst, University of Illinois College of Medicine at Urbana. "Calculation of Community Viral Load as an Indicator for HIV Programs in Champaign County Illinois." MENTOR: Janet A. Jokela, MD, MPH 
 
Hazar Khidir, Harvard Medical School. "HIV Risk and Harm Reduction in the Periconception Period for Serodiscordant Couples in Durban, South Africa." MENTOR: Lynn Matthews, MD, MPH 
 
Maya Koretzky, Johns Hopkins University School of Medicine. "Bedside Ethics, Provider Burnout, and Subsequent Career Trajectories: An Oral History of Interns and Residents at HIV Centers at the Height of the American Epidemic (1982-1986)." MENTOR: Robert Siliciano, MD, PhD 
 
Michael Scolarici, Saint Louis University School of Medicine. "Use of a Validated Risk Assessment Tool to Assess Additional Variables in the Risk of Progression to Active TB in Patients with HIV and Latent TB Infection." MENTOR: Soumya Chatterjee, MD 
 
Yanni Chang, University of Washington. "Focus Groups to Analyze Acceptability of HIV Pre-Exposure Prophylaxis and Self-Testing Among Female Sex Workers in Pune, India." MENTOR: Ann Duerr, MD, PhD, MPH


< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
FDA Alerts Health Facilities of M. Chimaera Due to Heater-cooler devices; CDC Continued Updates on Zika Testing
Guidelines Survey: Please Take 10 Minutes to Share Your Feedback
CLINICAL PRACTICE MANAGEMENT
Antimicrobial Stewardship Programs via Telehealth
IDSA Webinar Explains CMSís Proposed New Payment Program
POLICY AND ADVOCACY
IDSA Continues to Drive Legislative Progress on Antimicrobial Resistance
Zika Funding Remains in Limbo
Senate Bill Would Increase Funding for Antibiotic Resistance, But Impose Cuts Elsewhere
HIVMA Endorses the Equality Act
GLOBAL HEALTH
Science Speaks Covers UN Meeting on Ending AIDS
EDUCATION AND RESOURCES
IDWeek Mentorship Program
IDSA Foundation Offers Three Research Awards in 2016
HIVMA Medical Student Program Aims to Inspire Careers in HIV
Support IDSA Foundation Through CFC
ABIM Seeks Your Input on MOC Exams
New CDC and Mass General Resource Helps Travelers Stay Healthy
FROM THE PRESIDENT
Antimicrobial Resistance: Persistence Pays Off With This Strategic Priority
TOP STORIES
New IDSA Guideline on Diagnosis and Treatment of Aspergillosis
OPAT Handbook Now Available in Interactive, Digital Format
Donít Miss the Meeting Everyone Will be Talking About at IDWeek 2016!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.